Page 10 - Therapeutic Development Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) and Heska (NASDAQ:HSKA – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Institutional and Insider Ownership 5.6% of Navidea Biopharmaceuticals shares are […]

Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) and VolitionRx (NYSE:VNRX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings. Profitability This table compares Navidea Biopharmaceuticals and VolitionRx’s net margins, […]

Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) and StageZero Life Sciences (OTCMKTS:SZLSF – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation. Risk & Volatility Navidea Biopharmaceuticals has a beta […]

/PRNewswire/ -- The "Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders...

/PRNewswire/ -- The "Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders...